David McMullin, MBA

David is the Chief Business Officer at Anumana, Inc., where he leads strategy and commercialization for ECG-AI software designed to enable earlier detection of cardiovascular disease and smoother clinical workflows. His work includes advancing partnerships and regulatory milestones around Anumana’s FDA-cleared ECG-AI algorithms and ecosystem integrations.

Previously, David served as Chief Strategy Officer at nference, and before that held senior commercial roles including Chief Business Officer at Aldeyra Therapeutics, Group Vice President for U.S. Internal Medicine at Shire, and Vice President of Global Supply Chain Operations & Strategy at Novartis Vaccines & Diagnostics.

David earned his MBA from Harvard Business School (Baker Scholar) and a BA in Economics from Brigham Young University.